Oct 8, 2021 This Week in Cardiology Podcast
This Week in Cardiology
Medscape Podcasts
4.9 • 963 Ratings
🗓️ 8 October 2021
⏱️ 24 minutes
🧾️ Download transcript
Summary
Two NEJM papers on mRNA-related myocarditis, AF and stroke, intensifying BP meds, and CCTA and high-sensitivity troponin are the topics John Mandrola, MD, covers in this week's podcast. To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I -- Vaccine-Induced Myocarditis
New Reports Help Nail Down Myocarditis Risk With COVID-19 Vaccine
https://www.staging.medscape.com/viewarticle/960537
• Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
https://www.nejm.org/doi/full/10.1056/NEJMoa2109730
• Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
https://www.nejm.org/doi/full/10.1056/NEJMoa2110737
II – AF and Stroke
AF a Stroke Cause or Innocent Bystander? The Debate Continues
https://www.medscape.com/viewarticle/960224
• Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke
https://jamanetwork.com/journals/jamacardiology/fullarticle/2784332
• It's Time to Rethink (and Retrial) Our Framework for Stroke Prevention in Atrial Fibrillation
https://jamanetwork.com/journals/jamacardiology/fullarticle/2784335
III- Intensification of BP Control
Adding New Hypertensive May Be More Potent Than Upping Doses
https://www.medscape.com/viewarticle/960454
• Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults
https://doi.org/10.7326/M21-1456
IV- Hs-troponin and CAD
Troponin Levels Tied to Increased CAD Risk, May Guide Imaging /viewarticle/960146
• Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction
https://doi.org/10.1016/j.jacc.2021.07.055
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact
news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to this week in cardiology from the heart.org on medscape. |
| 0:09.7 | You can now access the latest in medical news on your Amazon Alexa enabled device. |
| 0:14.3 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute, where I highlight |
| 0:18.8 | the top medical stories of the day. |
| 0:21.1 | To add Medscape Medical Minute to your flash briefing, search for Medscape |
| 0:24.4 | Medical Minute on Amazon and click enable. Or open the Amazon Alexa app, go to |
| 0:29.0 | Skills, search for Medscape Medical Minute and click enable. Then say, |
| 0:33.4 | Alexa, what's the news or Alexa, what's my flash briefing? I hope you'll join us. |
| 0:38.6 | Hi everyone, this is John Mandrola from the Heart.org Medscape Cardiology. |
| 0:44.0 | And this is this week in Cardiology for October 8th, 2021. |
| 0:49.0 | This week, the Lamingland Journal of Medicine publishes two papers on messenger RNA vaccine |
| 0:54.4 | related myocarditis, atrophobulation and stroke, intensifying blood pressure |
| 0:59.6 | medications, and coronary to CTA and high sensitivity triponens. |
| 1:05.2 | First an announcement. |
| 1:06.7 | Next week I'll be at the European Association of Cardiothoracic Surgery |
| 1:11.6 | meeting in Barcelona and this week in |
| 1:15.0 | cardiology will take a break and return in two weeks. On Wednesday of |
| 1:21.1 | this week, New England Journal of Medicine published two observational studies, both from Israel, which characterized the prevalence and clinical features of post-Messinger RNA vaccine myocarditis. |
| 1:32.0 | The first paper, first author, Mevarich, retrospectively reviewed data |
| 1:38.0 | from late December 2020 to May 31st, 2021 regarding all cases of myocarditis in the Israeli health system. |
| 1:47.0 | Now recall that Israel was a world leader in early COVID vaccination. |
| 1:52.0 | The denominator of this study was huge at 5.1 million people who |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.